Risultati di ricerca
5 giorni fa · Asthma is a long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and easily triggered bronchospasms. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath.
5 giorni fa · Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.
5 giorni fa · Mai 2023. Asthma bronchiale: Mehr Erkrankungen, aber gute Versorgung in Deutschland. Immer mehr Menschen erkranken an Asthma bronchiale. Dies geht aus dem neuen Weißbuch Lunge 2023 hervor, das die Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) kürzlich vorgestellt hat.
4 giorni fa · Paris, May 22, 2024. Encouraging results from a phase 2 study showed that treatment with oral rilzabrutinib at both high dose and low doses led to a numerical reduction in loss of asthma control (LOAC) events (the primary endpoint) and improvements in symptoms in adult patients with uncontrolled moderate-to-severe asthma.
5 giorni fa · Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.
5 giorni fa · GSK said the treatment has the potential to be the first approved ultra-long-acting biologic with a six-month dosing schedule for severe asthma. GSK said it had positive results from phase III ...
5 giorni fa · May 21 (Reuters) - GSK's (GSK.L) experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects...
